MedTrace Logo

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

NCT02661438 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2018-12-19

No results posted yet for this study

Summary

The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.

Conditions

Interventions

DRUG

Placebo to Ciprofloxacin DPI (BAYQ3939)

Placebo to Ciprofloxacin DPI, 3 doses during test session, 1 additional dose for patients during device training

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-12
Primary Completion
2016-03-17
Completion
2016-03-17
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02661438 on ClinicalTrials.gov